Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 6811766)


Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.

Xiong T, Turner RM, Wei Y, Neal DE, Lyratzopoulos G, Higgins JP.

BMJ Open. 2014 May 15;4(5):e004285. doi: 10.1136/bmjopen-2013-004285.


Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.

Solanki AA, Liauw SL.

Open Access J Urol. 2011 Jun 15;3:95-104. doi: 10.2147/OAJU.S14245. Review.


Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy.

Degroot JM, Brundage MD, Lam M, Rohland SL, Heaton J, Mackillop WJ, Siemens DR, Groome PA.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E299-305. doi: 10.5489/cuaj.11294. Epub 2013 May 13.


Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.

Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DY, Sobczak M, Buyyounouski MK.

Radiother Oncol. 2011 Dec;101(3):508-12. doi: 10.1016/j.radonc.2011.07.022. Epub 2011 Aug 31.


Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.

Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK.

Cancer. 2011 Jul 1;117(13):2883-91. doi: 10.1002/cncr.25900. Epub 2011 Jan 10.


Carcinoma of the prostate.

Orovan WL, Demaria JE.

Can Fam Physician. 1985 Jun;31:1271-5.


Clinical Evidence: Non-metastatic prostate cancer.

Wilt TJ, Brawer MK.

West J Med. 1999 Aug;171(2):97-101. No abstract available.


Clinically localised prostate cancer.

Wilt TJ, Thompson IM.

BMJ. 2006 Nov 25;333(7578):1102-6. Review. No abstract available.


Prostate cancer treatment. The case for radical prostatectomy.

Goldstraw MA.

Ann R Coll Surg Engl. 2006 Sep;88(5):439-42. Review. No abstract available.


Selecting candidates for radical prostatectomy.

Lepor H.

Rev Urol. 2000 Summer;2(3):182-9.


Screening for prostatic cancer.

Harwood RH.

BMJ. 1993 Mar 27;306(6881):855. No abstract available.


Cancer of the prostate.

Dearnaley DP.

BMJ. 1994 Mar 19;308(6931):780-4. Review. Erratum in: BMJ 1994 Apr 9;308(6934):975.


Immediate versus deferred treatment for early prostatic cancer.

Smith PH, Armitage TG.

Postgrad Med J. 1987 Dec;63(746):1055-60. Review.


Managing localised cancer of the prostate.

Ritchie AW.

Br Med J (Clin Res Ed). 1988 Mar 19;296(6625):810. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk